These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 20589886)
1. INa and IKir are reduced in Type 1 hypokalemic and thyrotoxic periodic paralysis. Puwanant A; Ruff RL Muscle Nerve; 2010 Sep; 42(3):315-27. PubMed ID: 20589886 [TBL] [Abstract][Full Text] [Related]
2. Muscle membrane excitability after exercise in thyrotoxic periodic paralysis and thyrotoxicosis without periodic paralysis. Arimura K; Arimura Y; Ng AR; Sakoda S; Higuchi I Muscle Nerve; 2007 Dec; 36(6):784-8. PubMed ID: 17722048 [TBL] [Abstract][Full Text] [Related]
3. Insulin resistance in subjects with a history of thyrotoxic periodic paralysis (TPP). Soonthornpun S; Setasuban W; Thamprasit A Clin Endocrinol (Oxf); 2009 May; 70(5):794-7. PubMed ID: 18759868 [TBL] [Abstract][Full Text] [Related]
5. [Recent progress on the searchs of pathogenesis of thyrotoxic periodic paralysis]. Shishiba Y Nihon Rinsho; 2006 Dec; 64(12):2339-47. PubMed ID: 17154102 [TBL] [Abstract][Full Text] [Related]
6. Thyrotoxic periodic paralysis and the sodium/potassium pump. Marx A; Ruppersberg JP; Pietrzyk C; Rüdel R Muscle Nerve; 1989 Oct; 12(10):810-5. PubMed ID: 2558311 [TBL] [Abstract][Full Text] [Related]
7. Mutation screening in Chinese hypokalemic periodic paralysis patients. Wang W; Jiang L; Ye L; Zhu N; Su T; Guan L; Li X; Ning G Mol Genet Metab; 2006 Apr; 87(4):359-63. PubMed ID: 16386935 [TBL] [Abstract][Full Text] [Related]
9. Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. Ryan DP; da Silva MR; Soong TW; Fontaine B; Donaldson MR; Kung AW; Jongjaroenprasert W; Liang MC; Khoo DH; Cheah JS; Ho SC; Bernstein HS; Maciel RM; Brown RH; Ptácek LJ Cell; 2010 Jan; 140(1):88-98. PubMed ID: 20074522 [TBL] [Abstract][Full Text] [Related]
10. Expression patterns of two potassium channel genes in skeletal muscle cells of patients with familial hypokalemic periodic paralysis. Kim JB; Lee GM; Kim SJ; Yoon DH; Lee YH Neurol India; 2011; 59(4):527-31. PubMed ID: 21891927 [TBL] [Abstract][Full Text] [Related]
11. Absence of ion channels CACN1AS and SCN4A mutations in thyrotoxic hypokalemic periodic paralysis. Ng WY; Lui KF; Thai AC; Cheah JS Thyroid; 2004 Mar; 14(3):187-90. PubMed ID: 15072700 [TBL] [Abstract][Full Text] [Related]
12. The clinical and genetic features in a cohort of mainland Chinese patients with thyrotoxic periodic paralysis. Li X; Yao S; Xiang Y; Zhang X; Wu X; Luo L; Huang H; Zhu M; Wan H; Hong D BMC Neurol; 2015 Mar; 15():38. PubMed ID: 25885757 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of thyrotoxic periodic paralysis. Lin SH; Huang CL J Am Soc Nephrol; 2012 Jun; 23(6):985-8. PubMed ID: 22460532 [TBL] [Abstract][Full Text] [Related]
14. Genetic variant rs623011 (17q24.3) associates with non-familial thyrotoxic and sporadic hypokalemic paralysis. Chu PY; Cheng CJ; Tseng MH; Yang SS; Chen HC; Lin SH Clin Chim Acta; 2012 Dec; 414():105-8. PubMed ID: 22910584 [TBL] [Abstract][Full Text] [Related]
15. A patient suffering from hypokalemic periodic paralysis is deficient in skeletal muscle ATP-sensitive K channels. Jovanović S; Du Q; Mukhopadhyay S; Swingler R; Buckley R; McEachen J; Jovanović A Clin Transl Sci; 2008 May; 1(1):71-4. PubMed ID: 20396605 [TBL] [Abstract][Full Text] [Related]
16. End-plate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis. Ruff RL; Lennon VA Ann Neurol; 1998 Mar; 43(3):370-9. PubMed ID: 9506554 [TBL] [Abstract][Full Text] [Related]
17. Association of novel single nucleotide polymorphisms in the calcium channel alpha 1 subunit gene (Ca(v)1.1) and thyrotoxic periodic paralysis. Kung AW; Lau KS; Fong GC; Chan V J Clin Endocrinol Metab; 2004 Mar; 89(3):1340-5. PubMed ID: 15001631 [TBL] [Abstract][Full Text] [Related]
18. Identification and functional characterization of Kir2.6 mutations associated with non-familial hypokalemic periodic paralysis. Cheng CJ; Lin SH; Lo YF; Yang SS; Hsu YJ; Cannon SC; Huang CL J Biol Chem; 2011 Aug; 286(31):27425-35. PubMed ID: 21665951 [TBL] [Abstract][Full Text] [Related]
19. Is thyrotoxic periodic paralysis a disease caused by muscle membrane dysfunction? Son YR; Kim NH; Kim DG; Park KS Muscle Nerve; 2017 Oct; 56(4):780-786. PubMed ID: 28006864 [TBL] [Abstract][Full Text] [Related]
20. NA+- and K+-channels as molecular targets of the alkaloid ajmaline in skeletal muscle fibres. Friedrich O; V Wegner F; Wink M; Fink RH Br J Pharmacol; 2007 May; 151(1):82-93. PubMed ID: 17351660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]